CFDs are a leveraged product and can result in losses that exceed deposits. Trading CFDs may not be suitable for everyone, so please ensure you fully understand the risks and take care to manage your exposure.

The weekly ASX momentum report

The weekly ASX momentum report looks at where the market is moving and the top stocks that are showing up in our different screens. This week Healthscope (HSO), Henderson Group (HGG) and Flight Centre (FLT) are all looking interesting to us for short-term trades.

CFDs are a leveraged product and can result in losses that exceed deposits. Trading CFDs may not be suitable for everyone, so please ensure you fully understand the risks and take care to manage your exposure.
Source: Bloomberg

Momentum has started to come out of the ASX’s uptrend of late. The index has been reluctant to break below 5300, but 5400 has been a level of strong resistance as well. The ASX has been increasingly rangebound between 5300 and 5400. The 20-day moving average has continued to provide support to the index, but the breathing space between it and 5400 has continued to narrow.

The MACD momentum indicator turned negative on 19 May, and everyone seems to be waiting for a close below the 20-day moving average now to lead to a sharp pullback in the index.

Valuations in the ASX continue at concerning levels. The forward price-to-earnings ratio reached 17.5 last week, a full 1.7 standard deviations above the long-term moving average. This means either prices are dramatically overestimating future earnings, or future earnings are dramatically underestimating growth.

Although a big driver of this could be discrepancies between more cautious commodity price forecasts in earnings estimates and stock prices that have already locked in US$65 a barrel for oil.

Short positions have grown most noticeably in Dexus Property Group (DXS) possibly reflecting investor disappointment at its failed takeover of the Investa Office Fund and also increasing concern with the frothy-looking Sydney commercial real estate market. The increases in shorts in API, Saracen Mineral Holdings Ltd and Healthscope Ltd all look to be driven by a growing sense, for some investors, that price has been getting ahead of fundamentals.

Stock Ticker Week on week % increase in short positions
DXS Dexus 29.8
API Australian Pharmaceuticals 25.4
SAR Saracen Mineral 14.4
HSO Healthscope 11.6
OFX Ozforex Group 11.1
SUN Suncorp 10.7
MFG Magellan Financial 9.2
ORA Orora 9.1
MPL Medibank 8.2
SIP Sigma Pharmaceuticals 7.1


Despite the big rally seen in Link Administration Holdings Pty Limited (LNK) of late, there seems to be increasing belief in the rally as short positions continue to peel off. FlexiGroup Ltd has seen some noticeable buying by insiders over the past few months, indicating they believe the sell-off to be overdone.

Further declines in short positions in the stock appear to be confirming these conclusions.

Stock Ticker Week on week % decrease in short positions
LNK Link Administration -19.8
FXL FlexiGroup -11.0
SGP Stockland -10.7
BXB Brambles -9.9
LLC Lendlease -9.9
TCL Transurban -9.5
DLX DuluxGroup -9.0
CWN Crown Resorts -7.4
TLS Telstra -6.8
BPT Beach Energy -6.7


News that Healthscope Ltd (HSO) completed a US$300 million private placement helped the stock gain 1.7% yesterday. It continues in a very strong uptrend supported by the 20-day moving average and looks to be targeting its February 2015 high of A$3.11. 

Henderson Group (HGG) surged 4.6% on Friday, but with more than 70% of its revenues coming from the UK, it looks set to be a key beneficiary on the ASX should the UK vote to remain in the EU. A$5.6 and A$6.4 look like the next key resistance levels. 

The massive volume seen in the Flight Centre (FLT) sell-off yesterday after it downgraded earnings did provoke a 'hammer reversal pattern' in the daily candle for that session. There are clearly some who believe the sell-off is overdone and are keen to buy the stock at this level.

This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.  Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. 

CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.

Find articles by analysts